• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Vasectomy Market

    ID: MRFR/MED/3282-HCR
    110 Pages
    Rahul Gotadki
    October 2025

    Vasectomy Market Research Report Information By Type (Conventional Vasectomy, No-Scalpel Vasectomy, Minimally Invasive Vasectomy), Drug (Anesthetics, Painkillers, Antibiotics), Patient (Humans, Animals), End User (Hospitals And Clinics) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Vasectomy Market Infographic

    Vasectomy Market Summary

    As per Market Research Future Analysis, the global vasectomy market is projected to grow at a CAGR of 7.4%, reaching a value of USD 27.46 billion from 2023 to 2032. Vasectomy is a permanent male sterilization procedure that effectively prevents pregnancy by cutting and sealing the vas deferens. The procedure is minimally invasive, typically completed in under 30 minutes, and allows patients to resume normal sexual activity within a week. The market is driven by increasing global population, hormonal disturbances, and rising gender equality, while challenges include the impact of COVID-19 on production and supply chains. The market is segmented by type, drugs, end-users, patients, and regions, with North America holding the largest market share due to high demand and advanced medical infrastructure.

    Key Market Trends & Highlights

    Key trends influencing the vasectomy market include technological advancements and changing societal attitudes towards male contraception.

    • Market expected to grow at a CAGR of 7.4% from 2023 to 2032.
    • North America holds the largest market share due to gender equality and healthcare demand.
    • COVID-19 pandemic significantly impacted production and supply chains.
    • Emerging technologies are creating new opportunities in the vasectomy market.

    Market Size & Forecast

    Market Size USD 27.46 Billion by 2032
    CAGR 7.4%
    Largest Regional Market North America

    Major Players

    Key players include Pfizer Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company Inc., Accurate Surgical & Scientific Instruments Corporation, and Sklar Surgical Instruments.

    Vasectomy Market Drivers

    Market Growth Projections

    The Global Vasectomy Market Industry is projected to experience substantial growth in the coming years. With a current valuation of 16.8 USD Billion in 2024, the market is anticipated to reach 34.0 USD Billion by 2035. This represents a significant increase, driven by various factors including rising awareness of family planning, technological advancements, and changing societal attitudes towards male contraception. The expected compound annual growth rate (CAGR) of 6.63% from 2025 to 2035 further underscores the potential for expansion within this sector. These projections indicate a robust future for the vasectomy market as it adapts to evolving consumer needs and preferences.

    Government Initiatives and Support

    Government initiatives and support play a crucial role in shaping the Global Vasectomy Market Industry. Many countries have implemented policies aimed at promoting family planning and reproductive health services, which include vasectomy. These initiatives often provide funding for educational programs and subsidized healthcare services, making vasectomy more accessible to the public. For instance, countries with robust family planning programs report higher rates of vasectomy acceptance. This governmental backing not only raises awareness but also encourages men to consider vasectomy as a responsible choice, contributing to the projected CAGR of 6.63% for the period from 2025 to 2035.

    Rising Awareness of Family Planning

    The increasing awareness surrounding family planning and reproductive health is a pivotal driver for the Global Vasectomy Market Industry. Educational campaigns and healthcare initiatives have emphasized the importance of responsible parenthood, leading to a growing acceptance of vasectomy as a viable option for permanent contraception. This trend is particularly evident in developed nations, where the demand for vasectomies is on the rise. As of 2024, the Global Vasectomy Market is valued at 16.8 USD Billion, reflecting a shift in societal attitudes towards male sterilization. This awareness is expected to further bolster market growth as more individuals consider vasectomy as a practical solution.

    Changing Attitudes Towards Male Contraception

    Changing attitudes towards male contraception are reshaping the Global Vasectomy Market Industry. Traditionally, contraceptive responsibility has been predominantly placed on women, but there is a noticeable shift as men increasingly recognize the importance of sharing this responsibility. This evolving mindset is fostering a more open dialogue about male sterilization options, including vasectomy. As societal norms continue to evolve, more men are likely to consider vasectomy as a practical and responsible choice. This cultural shift is expected to drive market growth, aligning with the overall trend of increasing acceptance of male contraceptive methods.

    Technological Advancements in Surgical Techniques

    Technological advancements in surgical techniques are significantly influencing the Global Vasectomy Market Industry. Innovations such as no-scalpel vasectomy and advanced anesthesia methods have improved patient experiences and outcomes, leading to increased adoption rates. These minimally invasive procedures reduce recovery times and complications, making vasectomy a more appealing option for men. As healthcare providers adopt these modern techniques, the market is likely to witness a surge in demand. The anticipated growth trajectory suggests that by 2035, the market could reach 34.0 USD Billion, driven by these advancements that enhance the overall efficacy and safety of the procedure.

    Increased Healthcare Access and Insurance Coverage

    Increased healthcare access and insurance coverage are significant factors driving the Global Vasectomy Market Industry. As healthcare systems evolve, more individuals gain access to reproductive health services, including vasectomy. Insurance providers are increasingly covering the costs associated with the procedure, reducing financial barriers for potential patients. This trend is particularly pronounced in regions where healthcare reforms have expanded coverage for family planning services. As a result, more men are likely to opt for vasectomy, contributing to the market's growth trajectory. The combination of improved access and financial support is expected to enhance the overall adoption rates of vasectomy.

    Key Companies in the Vasectomy Market market include

    Industry Developments

    Pfizer Inc. and BioNTech S.E. today announced that they had submitted an application to the U.S. Food and Drug Administration for emergency use authorization of an additional booster dose for the adults. The submission is completely based on the two-real world data sets from Israel.

    Future Outlook

    Vasectomy Market Future Outlook

    The Global Vasectomy Market is projected to grow at a 6.63% CAGR from 2024 to 2035, driven by rising awareness, technological advancements, and increasing demand for permanent contraception.

    New opportunities lie in:

    • Develop innovative minimally invasive vasectomy techniques to enhance patient comfort and recovery.
    • Expand telehealth services for pre- and post-operative consultations to improve accessibility.
    • Invest in educational campaigns targeting younger demographics to increase awareness and acceptance of vasectomy.

    By 2035, the Vasectomy Market is expected to demonstrate robust growth, reflecting evolving societal attitudes towards family planning.

    Market Segmentation

    By Type

    • Conventional Vasectomy
    • No-scalpel Vasectomy
    • Minimally Invasive Vasectomy

    By Drugs

    • Anesthetics
    • Painkillers
    • Antibiotics
    • Others

    By End-User

    • Hospital & Clinics
    • Research and academics
    • Others

    By Patients

    • Human
    • Animals

    By Regional Sectors

    • Asia-Pacific
    • Europe
    • South America
    • North America
    • Middle East & Africa

    Some of the key market players are

    • Pfizer Inc.
    • Abbott
    • GlaxoSmithKline plc.
    • Sanofi S.A.
    • Novartis AG
    • Bayer AG
    • Bristol Myers Squibb Company
    • Eli Lilly and Company Inc.
    • Accurate Surgical & Scientific Instruments Corporation
    • Sklar Surgical Instruments

    Report Scope

    Attribute/Metric Details
    Market Size 2022 N/A (USD Billion)
    Market Size 2023 N/A (USD Billion)
    Market Size 2032 27.46 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.4 % (2024- 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2022
    Market Forecast Period 2023 - 2032
    Historical Data 2019 - 2022
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Sklar Surgical Instruments, Advanced Meditech International and others
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers Rising demand due to growing population Increasing male-female equality Side effects of female contraception

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions